Edwards Lifesciences Enterprise Value over EBITDA Trend

Edwards Lifesciences Corporation -- USA Stock  

USD 114.11  1.03  0.91%

This module enables investors to look at Edwards Lifesciences various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Consolidated Income of 560.2 M, Cost of Revenue of 744.5 M or Earning Before Interest and Taxes EBIT of 735.1 M, but also many exotic indicators such as Interest Coverage of 83.0439, Long Term Debt to Equity of 0.2914 or Calculated Tax Rate of 22.793. This module is a perfect complement to use when analyzing Edwards Lifesciences Valuation or Volatility. It can also complement various Edwards Lifesciences Technical models. Additionally see analysis of Edwards Lifesciences Correlation with competitors.
Showing smoothed Enterprise Value over EBITDA of Edwards Lifesciences Corporation with missing and latest data points interpolated. Measures the ratio between Enterprise Value and Earnings Before Interest Taxes and Depreciation Amortization USD.
Enterprise Value over EBITDA  10 Years Trend  
Increasing
Stable
 Enterprise Value over EBITDA 
      Timeline 

Edwards Lifesciences Enterprise Value over EBITDA Over Time

2015-12-31  24.09 
2016-12-31  24.13 
2017-12-31  25.38 

Other Fundumenentals

 

Regression Statistics

Arithmetic Mean  19.73
Geometric Mean  18.64
Coefficient Of Variation  33.4
Mean Deviation  6.04
Median  23.02
Standard Deviation  6.59
Sample Variance  43.43
Range  16.48
R Value  0.19
Mean Square Error  45.97
R Squared  0.037739
Significance  0.55
Slope  0.36
Total Sum of Squares  477.73

Currently Trending

S   
 NYQ 
Purchased over 400 shares of
1 hour ago ago
Traded for 6.93
ECYT   
 NMS 
Purchased over 500 shares of
1 hour ago ago
Traded for 5.19
GM   
 NYQ 
Purchased over 60 shares of
1 hour ago ago
Traded for 45.61